Qube Research & Technologies (QRT)
NVCR icon

Qube Research & Technologies (QRT)’s NovoCure NVCR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.18M Buy
605,874
+449,252
+287% +$6.8M 0.01% 1336
2026
Q1 		$1.71M Sell
156,622
-156,596
-50% -$1.96M ﹤0.01% 2257
2025
Q4 		$4.05M Sell
313,218
-29,251
-9% -$376K ﹤0.01% 1885
2025
Q3 		$4.42M Buy
342,469
+161,520
+89% +$2.16M ﹤0.01% 1828
2025
Q2 		$3.22M Sell
180,949
-110,000
-38% -$1.92M ﹤0.01% 1959
2025
Q1 		$5.18M Buy
290,949
+275,096
+1,735% +$6.25M 0.01% 1508
2024
Q4 		$472K Sell
15,853
-124,782
-89% -$2.64M ﹤0.01% 2499
2024
Q3 		$2.2M Sell
140,635
-181,872
-56% -$3.3M ﹤0.01% 1726
2024
Q2 		$5.52M Sell
322,507
-467,853
-59% -$8.23M 0.01% 1217
2024
Q1 		$12.4M Buy
790,360
+16,529
+2% +$243K 0.02% 759
2023
Q4 		$11.6M Buy
+773,831
New +$10.4M 0.02% 685
2023
Q2 		– Sell
-75,885
Closed -$4.56M – 2806
2023
Q1 		$4.56M Buy
+75,885
New +$6.06M 0.02% 699
2022
Q1 		– Sell
-68,385
Closed -$5.13M – 2828
2021
Q4 		$5.13M Buy
+68,385
New +$6.86M 0.04% 546
2021
Q3 		– Sell
-114,007
Closed -$25.3M – 2605
2021
Q2 		$25.3M Buy
114,007
+95,161
+505% +$18.5M 0.29% 61
2021
Q1 		$2.49M Buy
+18,846
New +$2.98M 0.04% 562
2020
Q3 		– Sell
-114,408
Closed -$6.78M – 1984
2020
Q2 		$6.78M Buy
114,408
+107,712
+1,609% +$7.08M 0.1% 259
2020
Q1 		$451K Buy
+6,696
New +$529K 0.02% 594

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NVCR Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its NovoCure (NVCR) stake by 287% in Q2 2026, buying an estimated $6.8M and bringing the position to 605,874 shares worth $9.18M. The position accounts for 0.01% of the portfolio, ranked #1336.

Qube Research & Technologies (QRT) first reported a position in NVCR in Q1 2020 and has held it in 17 quarters since. The position peaked at $25.3M in Q2 2021. 217 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Qube Research & Technologies (QRT) held 605,874 shares of NovoCure worth $9.18M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 449,252 NovoCure shares in Q2 2026, an estimated $6.8M.
  • NovoCure made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1336 holding.
  • Qube Research & Technologies (QRT) first reported a position in NovoCure in Q1 2020 and has held it in 17 quarters since.
  • Qube Research & Technologies (QRT)'s NovoCure position peaked at $25.3M in Q2 2021.
  • 217 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.